Incidence and risk factors for recurrent IgA nephropathy after kidney transplantation: A multicenter cohort study from Denmark
PLOS One · 20.07.2026 · 21 (7) · e0353887
DOI: 10.1371/journal.pone.0353887 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift PLOS One, online erschienen am 20.07.2026. Verfasst von Mette Thrane Øhrstrøm und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Renal Medicine, Aarhus University Hospital, Aarhus, Denmark. Hauptthemen laut MEDLINE: Glomerulonephritis, IGA, Kidney Transplantation. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nyreforeningen, Dansk Nefrologisk Selskab, Department of Renal Medicine, Aarhus University Hospital.
Abstract (Originalsprache)
Background
Recurrent immunoglobulin A nephropathy after kidney transplantation remains a major clinical challenge, but risk factors are not fully defined. This study aimed to evaluate the incidence of biopsy-proven recurrent IgAN and identify risk factors for recurrence in a contemporary Scandinavian cohort.
Methods
We conducted a multicenter cohort study including adult patients with biopsy-proven immunoglobulin A nephropathy who received a first kidney-only transplantation between 1990 and 2020 across two Danish transplantation centers. Recurrence incidence and associations with clinical and donor-related characteristics were assessed during follow-up.
Results
A total of 118 recipients were followed for a median of 5.5 years. Biopsy-confirmed recurrence occurred in 14% of patients, corresponding to a cumulative incidence of 16% at 10 years post-transplantation. Younger age at immunoglobulin A nephropathy diagnosis, faster progression to kidney failure, and receipt of a kidney from a living or genetically related donor were independently associated with an increased risk of recurrence. Maintenance post-transplant steroid use was not associated with recurrence. Recurrent immunoglobulin A nephropathy was associated with an increased risk of graft failure compared with non-recurrent disease (unadjusted HR 3.8; adjusted HR 6.7).
Conclusions
Recurrence of IgAN after kidney transplantation remains a clinically significant challenge, associated with younger age, rapid progression to KF, and transplantation from living or genetically related donors. Maintenance post-transplant steroid use was not associated with recurrence risk in this cohort. Larger and more diverse cohorts are warranted to clarify donor-related risk, strengthen the evidence on immunosuppressive protocols and guide strategies to improve graft outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Renal Medicine, Aarhus University Hospital, Aarhus, Denmark.
- Department of Nephrology, Odense University Hospital, Odense, Denmark.
- Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
- Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
ORCID-Profile: Mette Thrane Øhrstrøm
Förderung
- Nyreforeningen
- Dansk Nefrologisk Selskab
- Department of Renal Medicine, Aarhus University Hospital
Zitieren
APA
Øhrstrøm, M. T., Schultz, M. D., Bistrup, C., & Birn, H. (2026). Incidence and risk factors for recurrent IgA nephropathy after kidney transplantation: A multicenter cohort study from Denmark. PLOS One, 21(7), e0353887. https://doi.org/10.1371/journal.pone.0353887
Vancouver
Øhrstrøm MT, Schultz MD, Bistrup C, Birn H. Incidence and risk factors for recurrent IgA nephropathy after kidney transplantation: A multicenter cohort study from Denmark. PLOS One. 2026;21(7):e0353887. doi:10.1371/journal.pone.0353887
BibTeX
@article{hrstrm2026,
author = {Øhrstrøm, Mette Thrane and Schultz, Michael Dyrehauge and Bistrup, Claus and Birn, Henrik},
title = {Incidence and risk factors for recurrent IgA nephropathy after kidney transplantation: A multicenter cohort study from Denmark},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {7},
pages = {e0353887},
doi = {10.1371/journal.pone.0353887}
}
EUVIMED